By: Stephanie Armour
Lower prices would take effect in 2026 depending on the talks between the U.S. and drugmakers and the outcome of industry lawsuits.
Stephanie Armour is a senior healthcare policy reporter for The Wall Street Journal. With a focus on national issues in the United States, Stephanie covers a wide range of topics related to healthcare, including Medicaid, abortion, drug pricing, and the intersection of veterinary and human health. Her work has also been featured in MarketWatch.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Stephanie Armour's coverage heavily focuses on government announcements and legal policy regulations within the United States, particularly in the areas of politics, health, healthcare & pharmaceuticals. She may be receptive to pitches offering expert commentary or insights related to recent government announcements and regulatory changes in these sectors.
Given her focus on specific topics such as healthcare, mental health, drug prices, abortion rights among others; she would likely be interested in sources who can provide nuanced perspectives or data-driven insights into these issues.
It is important for potential sources reaching out to Stephanie to have a strong understanding of U.S. policies and regulations relating to the topics covered within her articles.
This information evolves through artificial intelligence and human feedback. Improve this profile .